📌 Key Takeaways
- Topic: Silica as a Clarifying Agent: Uses in Beer, Wine and Beverages
- Keywords: silica HS code
- Published: 2026-11-20 02:34:47
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for HPLC: Particle Types, Pore Sizes and Column Performance
- PPG Hi-Sil: Precipitated Silica Product Range and Applications
- Quartz Sand for Photovoltaic: High Purity Requirements for Solar Crucibles
- Silica for Printing Ink: Functions, Grades and Formulation Tips
- Silica Gel Desiccant: How It Works, Types, Capacity and How to Choose
- Chen, G. et al. Lanthanide-doped ultrasmall yttrium fluoride nanoparticles with improved multicolor upconversion photoluminescence. J. Mater. Chem. 22, 20190-20196 (2012). Article CAS Google Scholar
Spherical vs Angular Silica: Which Filler Performs Better and When?
What is silica (SiO₂)?
E551
What is the difference between fumed silica and precipitated silica?
silica for LED encapsulant
What drives silica raw material prices?
silica for sale Along with targeted ligand, cell membrane-based biomimetic strategy is also a current and really feasible approach to enhance the targeting skill of MSNs (Fig. 6b ). The cell membrane biomimetic method dates back to 2011, when Zhang's group used intact red blood cell membranes to encapsulate NPs via a top-down strategy. Compared with unencapsulated NPs, NPs encapsulated by red blood cell membranes have a longer half-life in mice and remain in circulation for up to 72 h due to the immune escape function possessed by the cell membrane. 326 The preparation process is typically divided into three steps: membrane extraction, preparation of inner core NPs, and fusion of membrane and NPs. The cell membrane-coated NPs combine the benefits of outer cells and inner core NPs, and achieve long-term in vivo circulation and targeted delivery while greatly improving biocompatibility. 327 The therapeutic potential of diverse types of cell membranes-engineered MSNs-based drug delivery systems has been demonstrated in a variety of disease models. For example, platelet membrane-coated MSNs were used for early atherosclerosis therapy by mimicking the immune escape ability of platelet. 328 Cancer cell membrane-coated MSNs were specifically enriched in tumor sites by homologous targeting properties, and activated the ferroptosis-related immunogenic cell death on gastric cancer. 329 Bacterial outer membrane-coated MSNs are used for targeted delivery of the antibiotic rifampicin to achieve in vivo resistance to gram-negative bacterial infections. 330 Despite the limitations of current research related to cell membrane biomimetic tactic, these instances invariably show the effectiveness of cell membrane-based active targeting strategy in enhancing the targeting ability and therapeutic efficacy of MSNs.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.